InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Bush Jennifer. Director active across 1 company, notably Artiva Biotherapeutics, Inc.. Cumulatively, 7 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €81k. History available since 12 September 2024. The latest transaction was filed on 3 September 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Jennifer Bush is a declarant linked to Artiva Biotherapeutics, Inc., where the listed role is COO, CLO, Secy, Compliance Off. The record shows 6 filings in total, and across the 6 recent sampled filings, buy and sell volumes are both 0 EUR, with Attribution transactions from 2024-09-13 to 2026-02-18.